Research and innovation in personalized medicine: a descriptive synthesis of actors in the EU and China

Francesco Andrea Causio; Ilda Hoxhaj; Flavia Beccia; Marzia Di Marcantonio; Timo Strohäker; Chiara Cadeddu; Walter Ricciardi; Stefania Boccia

doi:10.2217/pme-2023-0003

Research and innovation in personalized medicine: a descriptive synthesis of actors in the EU and China

Francesco Andrea Causio
, Ilda Hoxhaj
, Flavia Beccia
, Marzia Di Marcantonio
, Timo Strohäker
, Chiara Cadeddu
, Walter Ricciardi
, Stefania Boccia

University Department of Life Sciences and Public Health
Università degli Studi di Padova
Faculty of Business Administration and Economics
Steinbeis Europa Zentrum (SEZ)
Università Cattolica del Sacro Cuore, Roma

Research output: Contribution to journal › Article › Academic › peer-review

5 Citations (Scopus)

Abstract

Aim: Research and innovation (R&I) actors are fundamental in shortening the translational gap of personalized medicine in health systems. In the context of the 'Integrating China in the International Consortium for Personalized Medicine' project, we aimed to map the current landscape of R&I actors in the field of personalized medicine in the EU and China. Methods: A two-phase desk research study was conducted. Results: We identified 78 R&I actors. Research and technology organizations were the most frequent in both the EU and China. The identified R&I actors were active in a wide range of fields. The EU and China have many different R&I actors addressing personalized medicine-related issues, with few characteristics in common. Conclusion: More efforts are needed to ensure these R&I actors are encouraged to work together to bridge each other's gaps.

Original language	English
Pages (from-to)	227-238
Number of pages	12
Journal	Personalized Medicine
Volume	20
Issue number	3
DOIs	https://doi.org/10.2217/pme-2023-0003
Publication status	Published - 1 May 2023
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2023 Future Medicine Ltd.

Access to Document

10.2217/pme-2023-0003

Cite this

@article{bfdd7b194e7b4d618747a85a29be22de,

title = "Research and innovation in personalized medicine: a descriptive synthesis of actors in the EU and China",

abstract = " Aim: Research and innovation (R\&I) actors are fundamental in shortening the translational gap of personalized medicine in health systems. In the context of the 'Integrating China in the International Consortium for Personalized Medicine' project, we aimed to map the current landscape of R\&I actors in the field of personalized medicine in the EU and China. Methods: A two-phase desk research study was conducted. Results: We identified 78 R\&I actors. Research and technology organizations were the most frequent in both the EU and China. The identified R\&I actors were active in a wide range of fields. The EU and China have many different R\&I actors addressing personalized medicine-related issues, with few characteristics in common. Conclusion: More efforts are needed to ensure these R\&I actors are encouraged to work together to bridge each other's gaps. ",

author = "Causio, \{Francesco Andrea\} and Ilda Hoxhaj and Flavia Beccia and Marcantonio, \{Marzia Di\} and Timo Stroh{\"a}ker and Chiara Cadeddu and Walter Ricciardi and Stefania Boccia",

note = "Publisher Copyright: {\textcopyright} 2023 Future Medicine Ltd.",

year = "2023",

month = may,

day = "1",

doi = "10.2217/pme-2023-0003",

language = "English",

volume = "20",

pages = "227--238",

journal = "Personalized Medicine",

issn = "1741-0541",

publisher = "Taylor \& Francis Ltd (UK)",

number = "3",

}

TY - JOUR

T1 - Research and innovation in personalized medicine

T2 - a descriptive synthesis of actors in the EU and China

AU - Causio, Francesco Andrea

AU - Hoxhaj, Ilda

AU - Beccia, Flavia

AU - Marcantonio, Marzia Di

AU - Strohäker, Timo

AU - Cadeddu, Chiara

AU - Ricciardi, Walter

AU - Boccia, Stefania

PY - 2023/5/1

Y1 - 2023/5/1

N2 - Aim: Research and innovation (R&I) actors are fundamental in shortening the translational gap of personalized medicine in health systems. In the context of the 'Integrating China in the International Consortium for Personalized Medicine' project, we aimed to map the current landscape of R&I actors in the field of personalized medicine in the EU and China. Methods: A two-phase desk research study was conducted. Results: We identified 78 R&I actors. Research and technology organizations were the most frequent in both the EU and China. The identified R&I actors were active in a wide range of fields. The EU and China have many different R&I actors addressing personalized medicine-related issues, with few characteristics in common. Conclusion: More efforts are needed to ensure these R&I actors are encouraged to work together to bridge each other's gaps.

AB - Aim: Research and innovation (R&I) actors are fundamental in shortening the translational gap of personalized medicine in health systems. In the context of the 'Integrating China in the International Consortium for Personalized Medicine' project, we aimed to map the current landscape of R&I actors in the field of personalized medicine in the EU and China. Methods: A two-phase desk research study was conducted. Results: We identified 78 R&I actors. Research and technology organizations were the most frequent in both the EU and China. The identified R&I actors were active in a wide range of fields. The EU and China have many different R&I actors addressing personalized medicine-related issues, with few characteristics in common. Conclusion: More efforts are needed to ensure these R&I actors are encouraged to work together to bridge each other's gaps.

U2 - 10.2217/pme-2023-0003

DO - 10.2217/pme-2023-0003

M3 - Article

C2 - 37195152

SN - 1741-0541

VL - 20

SP - 227

EP - 238

JO - Personalized Medicine

JF - Personalized Medicine

IS - 3

ER -